FR2608921B1 - Composition pharmaceutique contenant de la ranitidine - Google Patents
Composition pharmaceutique contenant de la ranitidineInfo
- Publication number
- FR2608921B1 FR2608921B1 FR878717295A FR8717295A FR2608921B1 FR 2608921 B1 FR2608921 B1 FR 2608921B1 FR 878717295 A FR878717295 A FR 878717295A FR 8717295 A FR8717295 A FR 8717295A FR 2608921 B1 FR2608921 B1 FR 2608921B1
- Authority
- FR
- France
- Prior art keywords
- pharmaceutical composition
- composition containing
- containing ranitidine
- ranitidine
- pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 title 1
- 229960000620 ranitidine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB868629781A GB8629781D0 (en) | 1986-12-12 | 1986-12-12 | Pharmaceutical compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2608921A1 FR2608921A1 (fr) | 1988-07-01 |
| FR2608921B1 true FR2608921B1 (fr) | 1991-04-12 |
Family
ID=10608930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR878717295A Expired - Lifetime FR2608921B1 (fr) | 1986-12-12 | 1987-12-11 | Composition pharmaceutique contenant de la ranitidine |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US5068249A (fr) |
| JP (1) | JP2590156B2 (fr) |
| KR (1) | KR960008228B1 (fr) |
| AT (1) | AT395373B (fr) |
| AU (1) | AU607451B2 (fr) |
| BE (1) | BE1000624A5 (fr) |
| CA (1) | CA1303993C (fr) |
| CH (1) | CH675207A5 (fr) |
| CZ (1) | CZ281599B6 (fr) |
| DE (1) | DE3742127C2 (fr) |
| DK (1) | DK167842B1 (fr) |
| FR (1) | FR2608921B1 (fr) |
| GB (2) | GB8629781D0 (fr) |
| HK (1) | HK19095A (fr) |
| IE (1) | IE60618B1 (fr) |
| IL (1) | IL84795A0 (fr) |
| IT (1) | IT1211967B (fr) |
| NL (1) | NL194431C (fr) |
| NZ (1) | NZ222879A (fr) |
| PH (1) | PH25390A (fr) |
| SE (1) | SE504333C2 (fr) |
| YU (1) | YU46561B (fr) |
| ZA (1) | ZA879338B (fr) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8925484D0 (en) * | 1989-11-10 | 1989-12-28 | Glaxo Group Ltd | Process |
| GB9019875D0 (en) * | 1990-09-11 | 1990-10-24 | Glaxo Group Ltd | Pharmaceutical compositions |
| US5169864A (en) * | 1991-11-15 | 1992-12-08 | Baxter International Inc. | Unbuffered premixed ranitidine formulation |
| WO1995010274A1 (fr) * | 1993-10-14 | 1995-04-20 | F.H. Faulding & Co. Limited | Composition pharmaceutique aqueuse |
| US5407687A (en) * | 1994-02-22 | 1995-04-18 | Glaxo Inc. | Ranitidine solid dosage form |
| EP0768897A1 (fr) * | 1994-07-06 | 1997-04-23 | Farmarc Nederland B.V. | Complexe d'inclusion de ranitidine |
| HU213598B (en) * | 1994-10-18 | 1997-08-28 | Ge Lighting Tungsram Rt | One-side socketed discharge lamp |
| US5538737A (en) * | 1994-11-30 | 1996-07-23 | Applied Analytical Industries, Inc. | Oral compositions of H2 -antagonists |
| US5976578A (en) * | 1996-10-10 | 1999-11-02 | Mcneil-Ppc, Inc. | Liquid antacid compositions |
| GB9715423D0 (en) | 1997-07-23 | 1997-09-24 | Glaxo Group Ltd | Aqueous compositions |
| KR100412290B1 (ko) * | 2001-11-27 | 2003-12-31 | 주식회사 동구제약 | 라니티딘 함유 현탁제 조성물 및 그의 제조방법 |
| US20060100271A1 (en) * | 2004-11-08 | 2006-05-11 | Keith Whitehead | Stabilized aqueous ranitidine compositions |
| US8591938B2 (en) | 2006-07-21 | 2013-11-26 | Lyne Laboratories, Inc. | Liquid compositions of calcium acetate |
| GR1009069B (el) * | 2015-01-05 | 2017-07-07 | Λαμδα Φαρμακευτικα Εργαστηρια Εφαρμοσμενης Ερευνας & Αναπτυξης Α.Ε. | Ποσιμα διαλυματα υψηλης συγκεντρωσης που περιεχουν υδροχλωρικη ρανιτιδινη |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2735587A1 (de) * | 1977-08-06 | 1979-02-15 | Sandoz Ag | Stabile loesungen und verfahren zu deren herstellung |
| GB1565966A (en) * | 1976-08-04 | 1980-04-23 | Allen & Hanburys Ltd | Aminoalkyl furan derivatives |
| IL63968A (en) * | 1980-10-01 | 1985-10-31 | Glaxo Group Ltd | Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it |
| DE3108753A1 (de) * | 1981-03-07 | 1982-09-16 | Degussa Ag, 6000 Frankfurt | Neue substituierte alkyl-phenylsulfonylguanidine miteinem heterocyclischen rest |
| CA1211374A (fr) * | 1982-05-14 | 1986-09-16 | Eszter Cholnoky | Compose pharmaceutique contenant plus d'ingredients actifs |
| JPS59101478A (ja) * | 1982-11-29 | 1984-06-12 | Sunstar Inc | リグスチライドを安定に配合した水系組成物 |
| GB8313217D0 (en) * | 1983-05-13 | 1983-06-22 | Glaxo Group Ltd | Pharmaceutical compositions |
| SE8704436D0 (sv) * | 1987-11-13 | 1987-11-13 | Pm Konsult Handelsbolag | Anvendning av antisekretoriska substanser for nya indikationer |
-
1986
- 1986-12-12 GB GB868629781A patent/GB8629781D0/en active Pending
-
1987
- 1987-12-11 NL NL8703000A patent/NL194431C/nl not_active IP Right Cessation
- 1987-12-11 DK DK652787A patent/DK167842B1/da not_active IP Right Cessation
- 1987-12-11 IE IE336787A patent/IE60618B1/en not_active IP Right Cessation
- 1987-12-11 KR KR1019870014136A patent/KR960008228B1/ko not_active IP Right Cessation
- 1987-12-11 BE BE8701417A patent/BE1000624A5/fr not_active IP Right Cessation
- 1987-12-11 AU AU82444/87A patent/AU607451B2/en not_active Expired
- 1987-12-11 GB GB8728957A patent/GB2198352B/en not_active Expired - Lifetime
- 1987-12-11 DE DE3742127A patent/DE3742127C2/de not_active Expired - Lifetime
- 1987-12-11 IT IT8748698A patent/IT1211967B/it active
- 1987-12-11 SE SE8704952A patent/SE504333C2/sv not_active IP Right Cessation
- 1987-12-11 FR FR878717295A patent/FR2608921B1/fr not_active Expired - Lifetime
- 1987-12-11 JP JP62312419A patent/JP2590156B2/ja not_active Expired - Fee Related
- 1987-12-11 CA CA000554086A patent/CA1303993C/fr not_active Expired - Lifetime
- 1987-12-11 PH PH36204A patent/PH25390A/en unknown
- 1987-12-11 IL IL84795A patent/IL84795A0/xx not_active IP Right Cessation
- 1987-12-11 ZA ZA879338A patent/ZA879338B/xx unknown
- 1987-12-11 CH CH4842/87A patent/CH675207A5/fr not_active IP Right Cessation
- 1987-12-11 NZ NZ222879A patent/NZ222879A/xx unknown
- 1987-12-11 YU YU224587A patent/YU46561B/sh unknown
- 1987-12-11 AT AT0327387A patent/AT395373B/de not_active IP Right Cessation
-
1990
- 1990-03-14 US US07/494,804 patent/US5068249A/en not_active Expired - Lifetime
-
1991
- 1991-12-23 CZ CS914037A patent/CZ281599B6/cs not_active IP Right Cessation
-
1995
- 1995-02-09 HK HK19095A patent/HK19095A/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2586562B1 (fr) | Composition pharmaceutique contenant de l'a-methylhistamine | |
| FR2602974B1 (fr) | Composition pharmaceutique contenant de la nicotine ou ses derives | |
| IT1232677B (it) | Composizione farmaceutica contenente ranitidina | |
| FR2582513B1 (fr) | Compositions pharmaceutiques contenant de l'alfuzosine | |
| DE3784594D1 (de) | Mikrokapseln enthaltende pharmazeutische zusammensetzungen. | |
| FR2604357B1 (fr) | Composition pharmaceutique et cosmetique anti-acneique | |
| MC1782A1 (fr) | Preparation pharmaceutique | |
| IT1222104B (it) | Composizione farmaceutica idrosolubile contenente n acetilsisteina | |
| IT1222103B (it) | Composizione farmaceutica idrosolubile contenente n acetilcisteina | |
| FR2608921B1 (fr) | Composition pharmaceutique contenant de la ranitidine | |
| DE3575072D1 (de) | Pharmazeutische zusammensetzungen von mikrobenerzeugtem interleukin-2. | |
| FI872733A0 (fi) | Farmaceutiska kompositioner. | |
| FI872313A0 (fi) | Farmaceutiska kompositioner. | |
| FR2638640B1 (fr) | Solution pharmaceutique | |
| FR2598617B1 (fr) | Composition pharmaceutique | |
| FR2528425B1 (fr) | 1,4-dihydropyridines et composition pharmaceutique les contenant | |
| FR2609392B1 (fr) | Compositions pharmaceutiques contenant des pyranoquinoleines | |
| FR2647115B1 (fr) | Composition pharmaceutique de nedocromil sodique | |
| IT1216814B (it) | Composizioni farmaceutiche | |
| DE3577656D1 (de) | Pharmazeutische zusammensetzungen von ceftazidim. | |
| DE3669656D1 (de) | Azanaphthalene enthaltende arzneimittelzusammensetzungen. | |
| FR2605221B1 (fr) | Compositions pharmaceutiques ou veterinaires contenant de la de(hydroxymethyl)-25 deoxy-25 oxo-25 monensine | |
| FR2592883B1 (fr) | Derives de vinblastine et composition pharmaceutique les contenant | |
| FR2604358B1 (fr) | Procede de preparation de la cytidine-diphospho-dimethylethanolamine et composition pharmaceutique contenant ce compose | |
| ATE49124T1 (de) | Pharmazeutische zusammensetzungen von mikrobenerzeugtem interleukin-2. |